© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 17, 1320-1329,
September 4, 2002
© 2002 Oxford University Press
ARTICLE |
Amplification/Overexpression of a Mitotic Kinase Gene in Human Bladder Cancer
Affiliations of authors: S. Sen, H. Zhou, R.-D. Zhang, D. S. Yoon, F. Vakar-Lopez, S. Ito, F. Jiang, A. C. Ruifrok, R. L. Katz, B. Czerniak (Division of Pathology and Laboratory Medicine), D. Johnston (Department of Biomathematics), H. B. Grossman (Department of Urology), The University of Texas M. D. Anderson Cancer Center, Houston; W. Brinkley, Department of Cell Biology, Baylor College of Medicine, Houston.
Correspondence to: Bogdan Czerniak, M.D., Ph.D., The University of Texas M. D. Anderson Cancer Center, Department of Pathology, Box 085, 1515 Holcombe Blvd., Houston, TX 77030 (e-mail: bczernia{at}mdanderson.org).
Background: The mitotic kinase-encoding gene STK15/BTAK/ AuroraA is associated with aneuploidy and transformation when overexpressed in mammalian cells. STK15 overexpression activates an unknown oncogenic pathway that involves centrosome amplification and results in missegregation of chromosomes. Because clinical prognosis and tumor aneuploidy are tightly linked in human bladder cancer, we examined whether increased STK15 copy number and protein levels are linked to aneuploidy in bladder cancers. Methods: STK15 protein was visualized by immunohistochemistry in 205 formalin-fixed, paraffin-embedded human bladder tumors. STK15 gene copy number was evaluated in 61 tumors by Southern blot hybridization and in 21 of these 61 tumors by fluorescence in situ hybridization (FISH). Copy numbers of chromosomes 3, 17, 20, and 21 were evaluated by FISH with chromosome-specific probes. STK15 expression levels were related to histologic grade, stage, and DNA ploidy of the tumors and to the patients' follow-up data. The chi-square test for association was used to analyze the relationship between STK15 expression and pathologic features. All statistical tests were two-sided. Results: Tumors with low levels of STK15 amplification (3–4 copies) showed minimal deviation in their chromosome copy number and diploid or near-diploid total nuclear DNA content. Tumors with higher levels of STK15 amplification (>4 copies) had a major increase of chromosome copy number and of their total nuclear DNA content, i.e., exhibited pronounced aneuploidy. Elevated expression of STK15 was strongly associated with parameters of clinical aggressiveness including high histologic grade (P<.001), invasion (P<.001), increased rate of metastasis (P<.001), and decreased metastasis-free (P<.001) and overall (P<.001) survival of patients with bladder cancer. Conclusion: STK15 gene amplification and associated increased expression of the mitotic kinase it encodes are associated with aneuploidy and aggressive clinical behavior in human bladder cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Gautschi, J. Heighway, P. C. Mack, P. R. Purnell, P. N. Lara Jr., and D. R. Gandara Aurora Kinases as Anticancer Drug Targets Clin. Cancer Res., March 15, 2008; 14(6): 1639 - 1648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ogawa, K. Takenaka, H. Katakura, M. Adachi, Y. Otake, Y. Toda, H. Kotani, T. Manabe, H. Wada, and F. Tanaka Perimembrane Aurora-A Expression is a Significant Prognostic Factor in Correlation with Proliferative Activity in Non-Small-Cell Lung Cancer (NSCLC) Ann. Surg. Oncol., February 1, 2008; 15(2): 547 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Kulkarni, M. Loddo, E. Leo, M. Rashid, K. L. Eward, T. R. Fanshawe, J. Butcher, A. Frost, J. A. Ledermann, G. H. Williams, et al. DNA Replication Licensing Factors and Aurora Kinases are Linked to Aneuploidy and Clinical Outcome in Epithelial Ovarian Carcinoma Clin. Cancer Res., October 15, 2007; 13(20): 6153 - 6161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lassmann, Y. Shen, U. Jutting, P. Wiehle, A. Walch, G. Gitsch, A. Hasenburg, and M. Werner Predictive Value of Aurora-A/STK15 Expression for Late Stage Epithelial Ovarian Cancer Patients Treated by Adjuvant Chemotherapy Clin. Cancer Res., July 15, 2007; 13(14): 4083 - 4091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith, G. Oxford, A. S. Baras, C. Owens, D. Havaleshko, D. L. Brautigan, M. K. Safo, and D. Theodorescu Expression of Ral GTPases, Their Effectors, and Activators in Human Bladder Cancer Clin. Cancer Res., July 1, 2007; 13(13): 3803 - 3813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. LeRoy, J. J. Hunter, K. M. Hoar, K. E. Burke, V. Shinde, J. Ruan, D. Bowman, K. Galvin, and J. A. Ecsedy Localization of Human TACC3 to Mitotic Spindles Is Mediated by Phosphorylation on Ser558 by Aurora A: A Novel Pharmacodynamic Method for Measuring Aurora A Activity Cancer Res., June 1, 2007; 67(11): 5362 - 5370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Perez de Castro, G. de Carcer, and M. Malumbres A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy Carcinogenesis, May 1, 2007; 28(5): 899 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Lehman, R. Tibshirani, J. Y. Hsu, Y. Natkunam, B. T. Harris, R. B. West, M. A. Masek, K. Montgomery, M. van de Rijn, and P. K. Jackson Oncogenic Regulators and Substrates of the Anaphase Promoting Complex/Cyclosome Are Frequently Overexpressed in Malignant Tumors Am. J. Pathol., May 1, 2007; 170(5): 1793 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tanaka, Y. Hashimoto, T. Ito, K. Kondo, M. Higashiyama, S. Tsunoda, C. Ortiz, Y. Sakai, J. Inazawa, and Y. Shimada The Suppression of Aurora-A/STK15/BTAK Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Clin. Cancer Res., February 15, 2007; 13(4): 1331 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gu, Y. Gong, M. Huang, C. Lu, M. R. Spitz, and X. Wu Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians Carcinogenesis, February 1, 2007; 28(2): 350 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Akao, H. Matsuyama, Y. Yamamoto, K. Sasaki, and K. Naito Chromosome 20q13.2 Gain May Predict Intravesical Recurrence after Nephroureterectomy in Upper Urinary Tract Urothelial Tumors Clin. Cancer Res., December 1, 2006; 12(23): 7004 - 7008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Vischioni, J. J. Oudejans, W. Vos, J. A. Rodriguez, and G. Giaccone Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol. Cancer Ther., November 1, 2006; 5(11): 2905 - 2913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Reiter, P. Gais, U. Jutting, M. K. Steuer-Vogt, A. Pickhard, K. Bink, S. Rauser, S. Lassmann, H. Hofler, M. Werner, et al. Aurora Kinase A Messenger RNA Overexpression Is Correlated with Tumor Progression and Shortened Survival in Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., September 1, 2006; 12(17): 5136 - 5141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yamamoto, H. Matsuyama, S. Kawauchi, T. Furuya, X. P. Liu, K. Ikemoto, A. Oga, K. Naito, and K. Sasaki Biological characteristics in bladder cancer depend on the type of genetic instability. Clin. Cancer Res., May 1, 2006; 12(9): 2752 - 2758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Lopez-Rios, S. Chuai, R. Flores, S. Shimizu, T. Ohno, K. Wakahara, P. B. Illei, S. Hussain, L. Krug, M. F. Zakowski, et al. Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction. Cancer Res., March 15, 2006; 66(6): 2970 - 2979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-T. R. Yu, J.-M. Hsu, Y.-C. G. Lee, A.-P. Tsou, C.-K. Chou, and C.-Y. F. Huang Phosphorylation and Stabilization of HURP by Aurora-A: Implication of HURP as a Transforming Target of Aurora-A Mol. Cell. Biol., July 15, 2005; 25(14): 5789 - 5800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hata, T. Furukawa, M. Sunamura, S. Egawa, F. Motoi, N. Ohmura, T. Marumoto, H. Saya, and A. Horii RNA Interference Targeting Aurora Kinase A Suppresses Tumor Growth and Enhances the Taxane Chemosensitivity in Human Pancreatic Cancer Cells Cancer Res., April 1, 2005; 65(7): 2899 - 2905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Wu, T.-Y. Chen, C.-T. R. Yu, S.-J. Tsai, J.-M. Hsu, M.-J. Tang, C.-K. Chou, W.-J. Lin, C.-J. Yuan, and C.-Y. F. Huang Identification of V23RalA-Ser194 as a Critical Mediator for Aurora-A-induced Cellular Motility and Transformation by Small Pool Expression Screening J. Biol. Chem., March 11, 2005; 280(10): 9013 - 9022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tanaka, Y. Hashimoto, T. Ito, T. Okumura, T. Kan, G. Watanabe, M. Imamura, J. Inazawa, and Y. Shimada The Clinical Significance of Aurora-A/STK15/BTAK Expression in Human Esophageal Squamous Cell Carcinoma Clin. Cancer Res., March 1, 2005; 11(5): 1827 - 1834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Demidov, D. Van Damme, D. Geelen, F. R. Blattner, and A. Houben Identification and Dynamics of Two Classes of Aurora-Like Kinases in Arabidopsis and Other Plants PLANT CELL, March 1, 2005; 17(3): 836 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Dai, Q.-Y. Cai, X.-O. Shu, A. Ewart-Toland, W.-Q. Wen, A. Balmain, Y.-T. Gao, and W. Zheng Synergistic Effects of STK15 Gene Polymorphisms and Endogenous Estrogen Exposure in the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2065 - 2070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tong, Y. Zhong, J. Kong, L. Dong, Y. Song, M. Fu, Z. Liu, M. Wang, L. Guo, S. Lu, et al. Overexpression of Aurora-A Contributes to Malignant Development of Human Esophageal Squamous Cell Carcinoma Clin. Cancer Res., November 1, 2004; 10(21): 7304 - 7310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yamamoto, H. Matsuyama, T. Furuya, A. Oga, S. Yoshihiro, M. Okuda, S. Kawauchi, K. Sasaki, and K. Naito Centrosome Hyperamplification Predicts Progression and Tumor Recurrence in Bladder Cancer Clin. Cancer Res., October 1, 2004; 10(19): 6449 - 6455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Du and G. J. Hannon Suppression of p160ROCK bypasses cell cycle arrest after Aurora-A/STK15 depletion PNAS, June 15, 2004; 101(24): 8975 - 8980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Satinover, C. A. Leach, P. T. Stukenberg, and D. L. Brautigan Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein PNAS, June 8, 2004; 101(23): 8625 - 8630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Neben, A. Korshunov, A. Benner, G. Wrobel, M. Hahn, F. Kokocinski, A. Golanov, S. Joos, and P. Lichter Microarray-Based Screening for Molecular Markers in Medulloblastoma Revealed STK15 as Independent Predictor for Survival Cancer Res., May 1, 2004; 64(9): 3103 - 3111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rojanala, H. Han, R. M. Munoz, W. Browne, R. Nagle, D. D. Von Hoff, and D. J. Bearss The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer Mol. Cancer Ther., April 1, 2004; 3(4): 451 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-M. Jeng, S.-Y. Peng, C.-Y. Lin, and H.-C. Hsu Overexpression and Amplification of Aurora-A in Hepatocellular Carcinoma Clin. Cancer Res., March 15, 2004; 10(6): 2065 - 2071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hoque, J. Carter, W. Xia, M.-C. Hung, A. A. Sahin, S. Sen, and S. M. Lippman Loss of Aurora A/STK15/BTAK Overexpression Correlates with Transition of in Situ to Invasive Ductal Carcinoma of the Breast Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1518 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Warner, D. J. Bearss, H. Han, and D. D. Von Hoff Targeting Aurora-2 Kinase in Cancer Mol. Cancer Ther., June 1, 2003; 2(6): 589 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Gritsko, D. Coppola, J. E. Paciga, L. Yang, M. Sun, S. A. Shelley, J. V. Fiorica, S. V. Nicosia, and J. Q. Cheng Activation and Overexpression of Centrosome Kinase BTAK/Aurora-A in Human Ovarian Cancer Clin. Cancer Res., April 1, 2003; 9(4): 1420 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Li, J. Zhu, P. F. Firozi, J. L. Abbruzzese, D. B. Evans, K. Cleary, H. Friess, and S. Sen Overexpression of Oncogenic STK15/BTAK/Aurora A Kinase in Human Pancreatic Cancer Clin. Cancer Res., March 1, 2003; 9(3): 991 - 997. [Abstract] [Full Text] [PDF]
|
|